Gastroesophageal Reflux Disease as an Indication of Revisional Bariatric Surgery-Indication and Results-a Systematic Review and Metanalysis

Obes Surg. 2022 Sep;32(9):3156-3171. doi: 10.1007/s11695-022-06183-w. Epub 2022 Jul 1.

Abstract

This systematic review evaluates the indications and results of revisional bariatric surgery (RBS) in gastroesophageal reflux disease (GERD). A systematic literature search and meta-analysis was performed for articles published by April 1, 2021. After examining 722 papers involving 17,437 patients, 48 studies were included (n = 915 patients). RBS for GERD was mostly reported after sleeve gastrectomy (n = 796, 87%) and one anastomosis gastric bypass (n = 62, 6.8%) and was performed due to intractable GERD (71.6%), GERD and weight issues (16%), and biliary reflux (6.2%). Mean follow-up of the studies was 31.5 (3-84) months. Pooled estimation of a meta-analysis of studies reported 7% of GERD following primary surgery needing RBS, in which 99% of the patients experienced remission.

Keywords: Acid reflux; Alkaline reflux; Bile reflux; GERD; Primary bariatric surgery; Revisional bariatric surgery.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Bile Reflux* / surgery
  • Gastrectomy / methods
  • Gastric Bypass* / methods
  • Gastroesophageal Reflux* / surgery
  • Humans
  • Laparoscopy*
  • Obesity, Morbid* / surgery
  • Retrospective Studies